Crossmark

Synovial membrane-derived mesenchymal progenitor cells from osteoarthritic joints in dogs possess lower chondrogenic-, and higher osteogenic capacity compared to normal joints

Crossref DOI link: https://doi.org/10.1186/s13287-022-03144-z

Published Online: 2022-09-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Teunissen, M. https://orcid.org/0000-0003-0119-3257
Ahrens, N. S.

Snel, L.

Narcisi, R.

Kamali, S. A.

van Osch, G. J. V. M.

Meij, B. P.

Mastbergen, S. C.

Sivasubramaniyan, K.

Tryfonidou, M. A.
Funding

Funding for this research was provided by:

ReumaNederland (LLP9, LLP22)

Stichting voor de Technische Wetenschappen (P15-23)
License Information

Text and Data Mining valid from 2022-09-05

Version of Record valid from 2022-09-05
More Information

Article History

Received: 7 February 2022

Accepted: 17 August 2022

First Online: 5 September 2022

Declarations

:

: Synovial membrane was collected from dogs euthanized in unrelated experiments conducted in accordance with the guidelines set by the National Central Committee for Animal Experiments (AVD #115002016531). Synovial membrane from osteoarthritic knee joints was collected, with the owner’s consent, during standard-of-care surgery.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below